Terms: = Ovarian cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Treatment
30 results:
1. Biodegradable Local Chemotherapy Platform with Prolonged and Controlled Release of Doxorubicin for the Prevention of Local Tumor Recurrence.
Voznyuk AA; Makarets YA; Advakhova DY; Khafizov KA; Lugovoi ME; Zakharova VA; Senatov FS; Koudan EV
ACS Appl Bio Mater; 2024 Apr; 7(4):2472-2487. PubMed ID: 38480461
[TBL] [Abstract] [Full Text] [Related]
2. Biomarker Testing Journey Among Patients with Advanced Solid Tumors and treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study.
Shao C; Ren Y; Zhou H; Lee LC; Chen C; Dettman EJ; Cristescu R; Gozman A; Jin F; Zhou W
Adv Ther; 2024 Feb; 41(2):759-776. PubMed ID: 38169059
[TBL] [Abstract] [Full Text] [Related]
3. Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-
Shin YB; Choi JY; Shin DH; Lee JW
Int J Nanomedicine; 2023; 18():2209-2223. PubMed ID: 37152471
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
5. Development, Characterization, and In Vitro Evaluation of Cytotoxic Activity of Rutin Loaded pcl-PEG Nanoparticles Against Skov3 ovarian cancer Cell.
Firouzai-Amandi A; Tarahomi M; Rahmani Youshanlouie H; Mosaddeghi Heris R; Jafari-Gharabaghlou D; Zarghami N; Dadashpour M
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1951-1957. PubMed ID: 35763636
[TBL] [Abstract] [Full Text] [Related]
6. Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent ovarian cancer: a Proof-of-Concept Phase II Study.
Lampert EJ; Zimmer A; Padget M; Cimino-Mathews A; Nair JR; Liu Y; Swisher EM; Hodge JW; Nixon AB; Nichols E; Bagheri MH; Levy E; Radke MR; Lipkowitz S; Annunziata CM; Taube JM; Steinberg SM; Lee JM
Clin Cancer Res; 2020 Aug; 26(16):4268-4279. PubMed ID: 32398324
[TBL] [Abstract] [Full Text] [Related]
7. Improving the Anti-ovarian cancer Activity of Docetaxel by Self-Assemble Micelles and Thermosensitive Hydrogel Drug Delivery System.
Xu G; Zhu C; Li B; Wang T; Wan J; Zhang Y; Huang J; Yang D; Shen Y
J Biomed Nanotechnol; 2020 Jan; 16(1):40-53. PubMed ID: 31996284
[TBL] [Abstract] [Full Text] [Related]
8. Biocompatible Nanoclusters with High Heating Efficiency for Systemically Delivered Magnetic Hyperthermia.
Albarqi HA; Wong LH; Schumann C; Sabei FY; Korzun T; Li X; Hansen MN; Dhagat P; Moses AS; Taratula O; Taratula O
ACS Nano; 2019 Jun; 13(6):6383-6395. PubMed ID: 31082199
[TBL] [Abstract] [Full Text] [Related]
9. Development, characterization and biological in vitro assays of paclitaxel-loaded pcl polymeric nanoparticles.
Abriata JP; Turatti RC; Luiz MT; Raspantini GL; Tofani LB; do Amaral RLF; Swiech K; Marcato PD; Marchetti JM
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():347-355. PubMed ID: 30606542
[TBL] [Abstract] [Full Text] [Related]
10. Self-Assembled Honokiol-Loaded Microbubbles in the treatment of ovarian cancer by Ultrasound Irradiation.
Wu Q; Zhang M; Luo H; Yi T
J Biomed Nanotechnol; 2018 Oct; 14(10):1796-1805. PubMed ID: 30041725
[TBL] [Abstract] [Full Text] [Related]
11. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
Li X; Schumann C; Albarqi HA; Lee CJ; Alani AWG; Bracha S; Milovancev M; Taratula O; Taratula O
Theranostics; 2018; 8(3):767-784. PubMed ID: 29344305
[TBL] [Abstract] [Full Text] [Related]
12. Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast cancer.
Zhao EY; Shen Y; Pleasance E; Kasaian K; Leelakumari S; Jones M; Bose P; Ch'ng C; Reisle C; Eirew P; Corbett R; Mungall KL; Thiessen N; Ma Y; Schein JE; Mungall AJ; Zhao Y; Moore RA; Den Brok W; Wilson S; Villa D; Shenkier T; Lohrisch C; Chia S; Yip S; Gelmon K; Lim H; Renouf D; Sun S; Schrader KA; Young S; Bosdet I; Karsan A; Laskin J; Marra MA; Jones SJM
Clin Cancer Res; 2017 Dec; 23(24):7521-7530. PubMed ID: 29246904
[No Abstract] [Full Text] [Related]
13. A Complex Network of Tumor Microenvironment in Human High-Grade Serous ovarian cancer.
Kreuzinger C; Geroldinger A; Smeets D; Braicu EI; Sehouli J; Koller J; Wolf A; Darb-Esfahani S; Joehrens K; Vergote I; Vanderstichele A; Boeckx B; Lambrechts D; Gabra H; Wisman GBA; Trillsch F; Heinze G; Horvat R; Polterauer S; Berns E; Theillet C; Cacsire Castillo-Tong D
Clin Cancer Res; 2017 Dec; 23(24):7621-7632. PubMed ID: 28972047
[No Abstract] [Full Text] [Related]
14. Folate Receptor Targeted Delivery of siRNA and Paclitaxel to ovarian cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.
Jones SK; Lizzio V; Merkel OM
Biomacromolecules; 2016 Jan; 17(1):76-87. PubMed ID: 26636884
[TBL] [Abstract] [Full Text] [Related]
15. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
Scarano W; de Souza P; Stenzel MH
Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
[TBL] [Abstract] [Full Text] [Related]
16. Identification of high-affinity vegfr3-binding peptides through a phage-displayed random peptide library.
Shi LF; Wu Y; Li CY
J Gynecol Oncol; 2015 Oct; 26(4):327-35. PubMed ID: 26197772
[TBL] [Abstract] [Full Text] [Related]
17. Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Liu JF; Barry WT; Birrer M; Lee JM; Buckanovich RJ; Fleming GF; Rimel B; Buss MK; Nattam S; Hurteau J; Luo W; Quy P; Whalen C; Obermayer L; Lee H; Winer EP; Kohn EC; Ivy SP; Matulonis UA
Lancet Oncol; 2014 Oct; 15(11):1207-14. PubMed ID: 25218906
[TBL] [Abstract] [Full Text] [Related]
18. Polymeric micelles for apoptosis-targeted optical imaging of cancer and intraoperative surgical guidance.
Cho H; Cho CS; Indig GL; Lavasanifar A; Vakili MR; Kwon GS
PLoS One; 2014; 9(2):e89968. PubMed ID: 24587157
[TBL] [Abstract] [Full Text] [Related]
19. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.
Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP
Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815
[TBL] [Abstract] [Full Text] [Related]
20. Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.
Collinson F; Hutchinson M; Craven RA; Cairns DA; Zougman A; Wind TC; Gahir N; Messenger MP; Jackson S; Thompson D; Adusei C; Ledermann JA; Hall G; Jayson GC; Selby PJ; Banks RE
Clin Cancer Res; 2013 Sep; 19(18):5227-39. PubMed ID: 23935036
[TBL] [Abstract] [Full Text] [Related]
[Next]
